Moroctocog alfa
Moroctocog alfa
Moroctocog alfa (pronunciation: mo-roc-to-cog al-fa) is a recombinant form of Factor VIII, a protein that is essential for blood clotting. It is used in the treatment of Hemophilia A, a genetic disorder that prevents blood from clotting normally.
Etymology
The term "Moroctocog alfa" is derived from the words "Moro" and "tocog", which are abbreviations for "Molecular" and "Recombinant" respectively, and "alfa" which signifies that it is a first-generation product.
Usage
Moroctocog alfa is used to replace Factor VIII that is missing in people with Hemophilia A. It is injected into the bloodstream to help treat and prevent bleeding episodes in people with this condition. It is not used to treat Hemophilia B, which involves a different clotting factor.
Related Terms
- Factor VIII: A protein that helps blood to clot. It is missing or defective in people with Hemophilia A.
- Hemophilia A: A genetic disorder that prevents blood from clotting normally. It is caused by a lack or deficiency of Factor VIII.
- Recombinant DNA: DNA that has been formed by combining genetic material from different sources. Moroctocog alfa is produced using recombinant DNA technology.
See Also
External links
- Medical encyclopedia article on Moroctocog alfa
- Wikipedia's article - Moroctocog alfa
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski